India's Serum Institute plans to start vaccine production outside India - The Times
The Serum Institute of India, which manufactures the AstraZeneca COVID-19 vaccine, is planning to start vaccine production in other countries as it struggles to meet supply commitments, its chief executive officer told The Times.
India's Serum Institute plans to start vaccine production outside India. Photo: Reuters